EoCene Ltd. (EOCN) stock
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.46−0.07 (-2.77%)
Close on Nov 17, 2026Market cap $2.46MP/E –Yield –
EoCene price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
EoCene's price to sales ratio was 50.3× on Feb 28, 2020, against 159.6× a year earlier. Over the last 3 years it ranged from 43.4× to 261.8×, with a median of 134.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Feb 28, 2020 | 50.3× | −9.6 |
| 2019 | Dec 31, 2019 | 59.9× | −71.7 |
| 2018 | Dec 31, 2018 | 131.7× | −107.8 |
| 2017 | Dec 29, 2017 | 239.4× | – |
See a number that looks wrong?